| Mar 31, 2025 |
Apr 2, 2025 |
AbbVie Inc.
|
EVP, CHIEF COMMERCIAL OFFICER |
Sell |
15.0
|
-58,832
|
-51.88%
|
✗
|
$12.4M |
| Feb 28, 2025 |
Mar 4, 2025 |
AbbVie Inc.
|
EVP, CHIEF COMMERCIAL OFFICER |
Sell |
17.5
|
-20,226
|
-18.74%
|
✗
|
$4.1M |
| Mar 18, 2024 |
Mar 20, 2024 |
AbbVie Inc.
|
EVP, CHIEF COMMERCIAL OFFICER |
Sell |
15.0
|
-58,949
|
-48.63%
|
✗
|
$10.5M |
| Feb 28, 2024 |
Mar 1, 2024 |
AbbVie Inc.
|
EVP, CHIEF COMMERCIAL OFFICER |
Sell |
17.5
|
-26,121
|
-21.55%
|
✗
|
$4.7M |
| Mar 13, 2023 |
Mar 15, 2023 |
AbbVie Inc.
|
EVP, CHIEF COMMERCIAL OFFICER |
Sell |
16.3
|
-53,125
|
-46.03%
|
✗
|
$8.1M |
| Feb 28, 2023 |
Mar 2, 2023 |
AbbVie Inc.
|
EVP, COMMERCIAL OPERATIONS |
Sell |
17.5
|
-24,910
|
-21.02%
|
✗
|
$3.8M |
| Mar 24, 2022 |
Mar 25, 2022 |
AbbVie Inc.
|
EVP, Chief Commercial Officer |
Sell |
5.0
|
-27,690
|
-30.78%
|
✓
|
$4.4M |
| Feb 25, 2022 |
Mar 1, 2022 |
AbbVie Inc.
|
EVP, Chief Commercial Officer |
Sell |
3.8
|
-38,581
|
-38.25%
|
✓
|
$5.7M |
| Dec 15, 2021 |
Dec 17, 2021 |
AbbVie Inc.
|
EVP, Chief Commercial Officer |
Sell |
35.0
|
-2,152
|
-4.25%
|
✓
|
$275.5K |
| Dec 10, 2021 |
Dec 14, 2021 |
AbbVie Inc.
|
EVP, Chief Commercial Officer |
Sell |
22.5
|
-1,713
|
-3.27%
|
✗
|
$212.7K |
| Feb 28, 2021 |
Mar 2, 2021 |
AbbVie Inc.
|
SVP, US Commercial Operations |
Sell |
5.0
|
-24,730
|
-32.10%
|
✓
|
$2.7M |
| Dec 29, 2020 |
Dec 31, 2020 |
AbbVie Inc.
|
EVP, Commercial Operations |
Sell |
5.0
|
-25,290
|
-32.59%
|
✓
|
$2.7M |
| Dec 10, 2020 |
Dec 11, 2020 |
AbbVie Inc.
|
SVP, US Commercial Operations |
Sell |
22.5
|
-1,791
|
-3.31%
|
✗
|
$194.6K |
| May 12, 2020 |
May 12, 2020 |
AbbVie Inc.
|
SVP, US Commercial Operations |
Sell |
5.0
|
-23,024
|
-29.85%
|
✓
|
$2.1M |
| Feb 28, 2020 |
Mar 3, 2020 |
AbbVie Inc.
|
SVP, US Commercial Operations |
Sell |
20.0
|
-9,703
|
-11.18%
|
✗
|
$828.8K |
| Dec 10, 2019 |
Dec 12, 2019 |
AbbVie Inc.
|
SVP, US Commercial Operations |
Sell |
22.5
|
-1,713
|
-2.57%
|
✗
|
$148.1K |
| Aug 16, 2019 |
Aug 20, 2019 |
AbbVie Inc.
|
SVP, US Commercial Operations |
Buy |
100.0
|
+15,552
|
30.44%
|
✗
|
$1M |
| Feb 28, 2019 |
Mar 4, 2019 |
AbbVie Inc.
|
SVP, US Commercial Operations |
Sell |
20.0
|
-6,907
|
-12.19%
|
✗
|
$548.5K |